Piramal Pharma releases audio recording of Q2 FY2026 earnings call

Piramal Pharma Limited announced on November 6, 2025, the release of the audio recording of its conference call detailing the unaudited financial results for the quarter and half year ended September 30, 2025. This release is in accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The audio recording of the conference call, which took place on November 6, 2025, covers the standalone and consolidated unaudited financial results of the company for the specified period. Interested parties can access the recording directly on the company’s website at https://www.piramalpharma.com/financial-reports.

This announcement follows an earlier letter dated October 24, 2025, and ensures transparency regarding the company's financial disclosures. The communication was signed by Tanya Sanish, company secretary of Piramal Pharma Limited.